Hologic Inc.

Here are the stocks making the biggest market moves midday.

'Several diversity, equity, and inclusion demographic factors already impact the global economy,' Bank of America analysts say.

Jim Cramer says before you join the trading revolution, put down the slingshot and pick up the annual report. Here are his 7 tenets of smart trading.

Hologic lifted its first-quarter-profit forecast after selling 30 million coronavirus tests. The stock is higher.

It used to be bonds vs. stocks, Jim Cramer says, but now the tables have turned.

Hologic's coronavirus test for asymptomatic subjects has received emergency use authorization from the Food and Drug Administration.

Quest Diagnostics, one of the companies that make coronavirus-testing kits, is making a series of cost cuts, including staff furloughs and executive-pay cuts.

Here is TheStreet's latest news on the coronavirus and its worldwide and economic impact, and a timeline of events since January

Hologic CEO says coronavirus test kits are being shipped out, with more to come.

The decision to sell comes two years after Hologic bought Cynosure for $1.65 billion, with the medical aesthetics company having 'significantly underperformed our expectations,' says Hologic.

Jim Cramer puts the new tariffs in context and tells investors how to survive the trade war: Stand by some techs, and companies without China exposure.

Jim Cramer says that although a sell-off can breed a buying opportunity, investors need to worry about sky-high IPOs and other signs of froth.

Bitcoin futures trading kicks off on Sunday. You ready? Do you even care? Hey, the worst thing that could happen is that the avalanche of millionaires chasing bitcoin is so great the internet shuts down for hours.

As the market keeps reaching all-time highs, the mantra of 'buying low, sell high' isn't always that easy. Here's how to strategize.

American Water Works leads the S&P 500 for the most female representation on its board. But, there are still a handful of companies without any female directors.

The approval marks the first time that an immunotherapy has been combined with another drug to kill cancer cells more effectively.

From Abbott Labs to Wynn, these names rate checking out.

From Aetna to United Technologies, these names are hot.

Let's review the charts and indicators.

For now it looks like HOLX will try to move higher.

Outside of the pro sports world, it seems like amateur hour with regard to protocols.

$60 is our Point and Figure target so far.

It might be best to wait for a pullback in shares of the diagnostic and testing company before buying.

Two intriguing names are my choices for the year ahead.

Let's look at how the intermediate-term sentiment gauges have not shown much panic.

This list is not a buy list but a list of stocks that have been brought to new heights.

Let's see if the two are in alignment.

These 'bearish bets' are showing both technical and quantitative deterioration.

Let's check out the charts and indicators of this medical equipment maker.

FireEye, Achaogen, Hologic and LGI Homes present attractive values in a challenging market.

I have often found that insider buying in small- and mid-cap stocks can be a huge 'tell'.

These lesser-known diagnostic and life sciences firms are involved in areas from genetic tools to telemedicine.

Finding bullish and bearish reversals in the market.

This week's bullish and bearish reversal patterns.

Buy a shallow dip and price strength.

It's a wonder to me how split this market really is.

Stock is set to break out to the upside

The investment firm's analysts share their views about the precious metal.

UnitedHealth, still reeling from the murder of one of its top executives, is reportedly facing a Department of Justice investigation.

The federal agency has opted to make a drastic decision during a critical time of the year.